Beyond glycemic control: the neuroprotective potential of tirzepatide
Type 2 diabetes mellitus is linked to cognitive decline and an increased risk of neurodegenerative diseases. Tirzepatide, a medication that targets both the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, has shown therapeutic benefits beyond blood sugar regulatio...
| Published in: | Pharmacia |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-06-01
|
| Online Access: | https://pharmacia.pensoft.net/article/155150/download/pdf/ |